🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This open label trial is conducted to investigate the efficacy and safety o...
Status
Completed
Location
CHA Bundang Medical Center, CHA University
Start Date
2013-06
Trial ID
NCT01884155
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy before a donor peripheral blood...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2002-01-29
Trial ID
NCT00053989
Treatments Being Tested
In our prior study on the therapeutic mechanism of UCB, changes in cytokine...
Status
Completed
Location
CHA Bundang Medical Center
Start Date
2015-07-29
Trial ID
NCT03130816
Treatments Being Tested
RATIONALE: A peripheral stem cell, bone marrow, or umbilical cord blood tra...
Status
Completed
Location
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
Start Date
2005-04
Trial ID
NCT00112645
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
In this Phase I study, the study team will evaluate the safety of Valproic ...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2019-02-21
Trial ID
NCT03885947
Treatments Being Tested
This open-label study aims to evaluate the safety and efficacy of umbilical...
Status
Completed
Location
CHA Bundang Medical Center, CHA University
Start Date
2012-05
Trial ID
NCT01601158
Treatments Being Tested
Study evaluates the safety and primary efficiency of systemic (i.v.) alloge...
Status
Completed
Location
N.V. Sklifosovsky Emergency Care Institute
Start Date
2013-03-18
Trial ID
NCT04331405
Treatments Being Tested
To determine the safety of single and repeated intravenous doses of hCT-MSC...
Status
Completed
Location
Duke University
Start Date
2018-12-27
Trial ID
NCT03635450
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as alemtuzumab, can block cancer gro...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2005-01
Trial ID
NCT00301834